Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma 7Lymphoma, Large B-Cell, Diffuse 6Osteosarcoma 3Lymphoma, B-Cell 3Sarcoma, Ewing 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Penile Neoplasms 2Neurofibrosarcoma 2Liposarcoma 2Hemangiosarcoma 2Fibrosarcoma 2Burkitt Lymphoma 2Wilms Tumor 1Vascular Neoplasms 1Teratoma 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Pleuropulmonary blastoma 1Neuroblastoma 1Nerve Sheath Neoplasms 1Neoplasms, Adipose Tissue 1Neoplasm Metastasis 1Myoepithelioma 1Lymphoma, T-Cell, Peripheral 1

Interventions

elacestrant 1RAD1901 1Injections 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Sarcoma, Endometrial Stromal × Ifosfamide × Clear all
NCT06277154 2025-07-24

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

HRYZ Biotech Co.

Phase 2 Recruiting
148 enrolled
GynecologicSarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Endometrial Stromal, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡